News
TKPHF
32.13
NaN%
--
CHMP gives positive opinion on variation to marketing authorization for Adcetris
TipRanks · 1h ago
Johnson & Johnson Just Proved The Bears Wrong Again
Seeking Alpha · 1d ago
Grifols: A Market Setback Turns Into Buying Opportunity
Seeking Alpha · 2d ago
White Falcon Capital Q1 2025 Partner's Letter
Seeking Alpha · 2d ago
Takeda Completes Share Repurchase to Optimize Capital Structure
TipRanks · 3d ago
Weekly Report: what happened at TKPHF last week (0414-0418)?
Weekly Report · 4d ago
Weekly Report: what happened at TKPHF last week (0407-0411)?
Weekly Report · 04/14 11:29
Keros Therapeutics: Strategic Alternatives Could Bring About Value Creation
Seeking Alpha · 04/11 18:13
Trump's Tariffs Circle Pharma Industry: Who It Affects And How It May Play Out
Seeking Alpha · 04/09 19:59
Weekly Report: what happened at TKPHF last week (0331-0404)?
Weekly Report · 04/07 11:28
Takeda upgraded to Overweight from Equal Weight at Morgan Stanley
TipRanks · 04/02 09:10
Takeda & Protagonist: Rusfertide Clinical Success Bolsters Investment Returns
Seeking Alpha · 04/01 18:27
Takeda Updates on Share Repurchase Progress
TipRanks · 04/01 07:02
Weekly Report: what happened at TKPHF last week (0324-0328)?
Weekly Report · 03/31 11:41
Takeda Canada says Health Canada expands marketing authorization for HyQvia
TipRanks · 03/27 13:41
Mirum Pharmaceuticals partner Takeda receives approval for Livmarli in Japan
TipRanks · 03/27 13:11
Takeda Proposes Re-election of Directors Ahead of Leadership Transition
TipRanks · 03/26 09:52
Harmony Biosciences CCO Jeffrey Dierks steps down, Adam Zaeske succeedsTakeda
TipRanks · 03/24 12:26
Weekly Report: what happened at TKPHF last week (0317-0321)?
Weekly Report · 03/24 11:28
Weekly Report: what happened at TKPHF last week (0310-0314)?
Weekly Report · 03/17 11:40
More
Webull provides a variety of real-time TKPHF stock news. You can receive the latest news about Takeda Pharmaceutical Co Ltd through multiple platforms. This information may help you make smarter investment decisions.
About TKPHF
Takeda Pharmaceutical Co Ltd is a Japan-based company mainly engaged in the research and development, manufacture, sale and licensing of pharmaceuticals. The Company focuses on the main business areas of gastrointestinal diseases, rare diseases, plasma derivatives (immune diseases), oncology (cancer), and neuroscience (neuropsychiatric diseases). The Company focuses on three research and development areas: innovative biopharmaceuticals with the focus on gastrointestinal and inflammatory diseases, neuroscience, and oncology, plus plasma derivatives and vaccines. Most of the pharmaceuticals treat rare diseases in the focus disease areas and the plasma derivatives area. The Company operates in Japan, the United States, Europe, and China.